Troponin T: Newer magnetic immunoassay method of troponins as point-of-care detection of acute myocardial infarction

World Heart Journal

Volumn 3, Issue 1, 2010, Pages 17-29

  Sharma, R ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Acute myocardial infarction; Antitroponin; Cardiac muscle; Imaging; Magnetic immunoassay; MRI; Troponin

Indexed keywords

ANTIBODY; ANTIGEN; GLUCOSE; GLUCOSE OXIDASE; MAGNETIC NANOPARTICLE; NANOSPHERE; PEROXIDASE; POLYETHYLENE; POLYSTYRENE; TROPONIN; TROPONIN C; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ANTIBODY COMBINING SITE; ARTICLE; BLOOD GLUCOSE METER; BLOOD SAMPLING; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOASSAY; MAGNET; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; REACTION OPTIMIZATION; SENSITIVITY ANALYSIS; SOLID;

EID: 77956711166     PISSN: 15564002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin. Chem. 1992;38(11):2203-14.
2. Lin JC, Apple FS, Murakami MM, Luepker RV. Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes. Clin. Chem. 2004;50(2):333-8.
3. Lang K, Borner A, Figulla HR. Comparison of biochemical markers for the detection of minimal myocardial injury: superior sensitivity of cardiac troponin - T ELISA. J. Intern. Med. 2000;247(1):119-23.
4. Suetomi K, Takahama K.A sandwich enzyme immunoassay for cardiac troponin I. Nippon. Hoigaku Zasshi. 1995;49(1):26-32.
5. Apple FS, Anderson FP, Collinson P, Jesse RL, Kontos MC, Levitt MA, Miller EA, Murakami MM. Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction. Clin. Chem. 2000;46(10):1604-9.
6. Sharma R Search of Troponins as Smart Biosensors for Point-of-care Detection of Acute Myocardial Infarction. Proc. NSTI Nanotech 2007; Abstract 1222.
7. Hsu LF, Koh TH, Lim YL.Cardiac marker point-of-care testing: evaluation of rapid on-site biochemical marker analysis for diagnosis of acute myocardial infarction. Ann. Acad. Med. Singapore. 2000;29(4):421-7.
8. Newman DJ, Olabiran Y, Bedzyk WD, Chance S, Gorman EG, Price CP. Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin I. Clin. Chem. 1999;45(6 Pt 1):822-8.
9. Hetland O, Goransson L, Nilsen DW. Cardiac troponin T immunoassay on biotin - streptavidin-coated microplates: preliminary performance in acute myocardial infarction. Scand. J. Clin. Lab Invest. 1995;55(8):701-13.
10. Gao L, Zhuang J, Nie L, Zhang J, Zhang Y, Gu N, Wang T, Feng J, Yang D, Perrett S, and Yan X. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nature Nanotech 2007;2(9):521-583.
11. Zhang J. Directing cells to target tissues organs. USPTO Application #: 20070053839. http://www.freshpatents.com/Directing-cells-to-target-tissues- organs-dt20070308ptan20070053839.php
12. Jossi S, Gordon SL, Legge MA, Armstrong GP. All troponins are not created equal. Intern. Med. J. 2006;36(5):325-7.
13. Saadeddin SM, Habbab MA, Siddieg HH, Al Seeni MN, Tahery AB, Dafterdar RM.Evaluation of 6 cardiac troponin assays in patients with acute coronary syndrome. Saudi Med. J. 2003;24(10):1092-7.
14. Kratz A, Januzzi JL, Lewandrowski KB, Lee-Lewandrowski E.Positive predictive value of a point-of-care testing strategy on first-draw specimens for the emergency department-based detection of acute coronary syndromes. Arch Pathol. Lab Med. 2002;126(12):1487-93.
15. Zarich SW, Bradley K, Mayall ID, Bernstein LH.Minor elevations in troponin T values enhance risk assessment in emergency department patients with suspected myocardial ischemia: analysis of novel troponin T cut-off values. Clin. Chim Acta. 2004;343(1-2):223-9.
16. Wu AH, Smith A, Christenson RH, Murakami MM, Apple FS. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Clin. Chim Acta. 2004;346(2):211-9.
17. Takahashi M, Lee L, Shi Q, Gawad Y, Jackowski G.Use of enzyme immunoassay for measurement of skeletal troponin-I utilizing isoform-specific monoclonal antibodies. Clin. Biochem. 1996;29(4):301-8.
18. Larue C, Calzolari C, Bertinchant JP, Leclercq F, Grolleau R, Pau B.Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin. Chem. 1993;39(6):972-9.
19. Haug C, Bachem MG, Woehrle H, Hetzel M, Gruenert A.Evaluation of two modified cardiac troponin I enzyme immunoassays. Clin. Chem Lab Med. 2002;40(8):837-9.
20. Wu AH, Valdes R Jr, Apple FS, Gornet T, Stone MA, Mayfield-Stokes S, Ingersoll-Stroubos AM, Wiler B.Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clin. Chem. 1994;40(6):900-7.
21. Lestin M, Hergert M, Lestin HG, Brinker C, Storm H, Kuhrt E, Kuhrt B, Lambrecht HG, Kuhnel W. Evaluation of the chemiluminescence immunoassays for the measurement of troponin I, myoglobin and CK-MB using the IMMULITE system in comparison to other measuring systems. Clin. Lab. 2002;48(3-4):211-21.
22. Chatterjee J, Haik Y, Chen CJ. Modification and characterization of polystyrene based magnetic microspheres and its comparison with albumin based magnetic microspheres. J. Mag Mag Mat. 2001, 225:21-29.
23. Filatov VL, Katrukha AG, Bereznikova AV, Esakova TV, Bulargina TV, Kolosova OV, Severin ES, Gusev NB. Epitope mapping of anti-troponin I monoclonal antibodies. Biochem. Mol. Biol. Int. 1998;45(6):1179-87.
24. Haik Y, Chatterjee J, Chen CJ. Synthesis and stabilization of Fe-Nd-B nanoparticles for biomedical applications. J. Nanoparticle Res.2005, 7:675-679.
25. Song Zhang, Zhiping Bian, Chunrong Gu, Yu Zhang, Shiying He, Ning Gu, Jinan Zhang. Preparation of antihuman cardiac troponin I immunomagnetic nanoparticles and biological activity assays. Colloids Surf B Biointerfaces. 2006; http://www.wipo.int/pctdb/en/wo.jsp?WO=2007085411andIA=EP2007000537andDI SPLAY=DESC
26. Penttila I, Hirvonen K, Julkunen A, Penttila K, Rantanen T.Adaptation of the troponin T ELISA test to a microplate immunoassay reader. Eur. J. Clin. Chem. Clin. Biochem. 1995;33(1):59-63.
27. Amit G, Gilutz H, Cafri C, Wolak A, Ilia R, Zahger D.What have the new definition of acute myocardial infarction and the introduction of troponin measurement done to the coronary care unit? Impacts on admission rate, length of stay, case mix and mortality. Cardiology. 2004;102(3):171-6.
28. Apple FS, Chung AY, Kogut ME, Bubany S, Murakami MM.Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin. Chim Acta. 2006;.
29. Apple FS, Ler R, Chung AY, Berger MJ, Murakami MM.Point-of-care i-STAT cardiac troponin I for assessment of patients with symptoms suggestive of acute coronary syndrome. Clin. Chem. 2006;52(2):322-5.
30. Apple FS, Quist HE, Murakami MM.Diagnostic and prognostic value of cardiac troponin I assays in patients admitted with symptoms suggestive of acute coronary syndrome. Arch. Pathol. Lab Med. 2004;128(4):430-4..
31. Ogawa M, Abe S, Saigo M, Kozono T, Yamaguchi K, Toda H, Lee S, Yamashita T, Atsuchi Y, Tateishi S, Tahara M, Torii H, Akimoto M, Mawatari K, Fukusaki M, Tei C.Usefulness of rapid bedside cardiac troponin T assay for the diagnosis of acute myocardial infarction] J. Cardiol. 2000;35(3):157-64.
32. Heeschen C, Goldmann BU, Moeller RH, Hamm CW.Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I. Clin Chem. 1998;44(9):1925-30.
33. Muller-Bardorff M, Freitag H, Scheffold T, Remppis A, Kubler W, Katus HA.Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation. 1995;92(10):2869-75.
34. Torabi F, Mobini Far HR, Danielsson B, Khayyami M.Development of a plasma panel test for detection of human myocardial proteins by capillary immunoassay. Biosens Bioelectron. 2006.
35. Hirschl MM, Lechleitner P, Friedrich G, Sint G, Sterz F, Binder M, Dienstl F, Laggner AN. Usefulness of a new rapid bedside troponin T assay in patients with chest pain. Resuscitation. 1996;32(3):193-8.
36. Guo H, Yang D, Gu C, Bian Z, He N, Zhang J.Development of a low density colorimetric protein array for cardiac troponin I detection. J. Nanosci Nanotechnol. 2005;5(12):2161-6.
37. Meng QH, Zhu S, Booth C, Stevens L, Bertsch B, Qureshi M, Kalra J.Impact of the cardiac troponin testing algorithm on excessive and inappropriate troponin test requests. Am. J. Clin. Pathol. 2006;126(2):1-5.
38. James SK, Lindahl B, Armstrong P, Califf R, Simoons ML, Venge P, Wallentin L; GUSTO-IV ACS Investigators.A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes. Int. J. Cardiol. 2004;93(2-3):113-20.
39. Collinson PO, Gaze DC, Stubbs PJ, Swinburn J, Khan M, Senior R, Lahiri A.Diagnostic and prognostic role of cardiac troponin I (cTnI) measured on the DPC Immulite. Clin. Biochem. 2006.
40. Babuin L, Jaffe AS.Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ. 2005;173(10):1191-202.
41. Apple FS, Murakami MM, Christenson RH, Campbell JL, Miller CJ, Hock KG, Scott MG. Analytical performance of the i-STAT cardiac troponin I assay. Clin. Chim Acta. 2004;345(1-2):123-7.
42. Apple FS, Murakami MM, Quist HH, Pearce LA, Wieczorek S, Wu AH.Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/American College of Cardiology recommended cutoff values. Am. J. Clin. Pathol. 2003;120(1):114-20.
43. Labugger R, Simpson JA, Quick M, Brown HA, Collier CE, Neverova I, Van Eyk JE. Strategy for analyais of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin. Chem 2003;49(6):873-879.
44. Bizzarri M, Cavaliere C, Foglia P, Guarino C, Samperi R, Lagana A. A label free method based on MALDI TOF Mass spectrometry for the absolute quantitation of troponinT in mouse cardiac tissue. Ana Bioana Chem. 2008;391(5):1969-76.
45. Yang X, Wu H, Kobayashi T, Solaro RJ, van Breemen RB. Enhanced Ionization of Phosphorylated Peptides during MALDI TOF Mass Spectrometry Anal. Chem., 2004, 76 (5), pp 1532-1536.